Home LiteratureArticle Details
PMID: 8139703 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

P2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens.

Naunyn-Schmiedeberg's archives of pharmacology ·Vol. 349 ·No. 1 ·1994-01-00 ·Pages 74-80

Bültmann R, Starke K

Abstract

The sites of action at which ATP elicits contraction of the rat vas deferens were studied by means of the P2-purinoceptor antagonists pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (iso-PPADS), suramin and reactive blue 2. Increasing concentrations of iso-PPADS (up to 1 mM), suramin (up to 1 mM) and reactive blue 2 (up to 320 microM) reduced and eventually abolished contractions elicited by the P2x-purinoceptor-selective agonist alpha,beta-methylene ATP 3 microM with IC50 values of 2.1, 10.1 and 27.0 microM, respectively. In contrast, iso-PPADS and suramin caused only a partial inhibition of contractions elicited by ATP 1 mM, maximal reduction by about 40%, IC50 values 1.3 and 5.0 microM, respectively; reactive blue 2 did not change ATP-induced contractions. In tissues exposed to iso-PPADS 320 microM throughout, increasing concentrations of reactive blue 2 or suramin decreased contractions elicited by ATP 1 mM, IC50 values 2.6 and 14.5 microM, respectively. In tissues exposed to suramin 320 microM throughout, increasing concentrations of iso-PPADS decreased contractions elicited by ATP 1 mM, IC50 37.9 microM, whereas reactive blue 2 slightly enhanced these contractions. In tissues exposed to reactive blue 2 100 microM throughout, increasing concentrations of iso-PPADS reduced contractions elicited by ATP 1 mM, IC50 26.6 microM, whereas suramin caused no change. Pre-exposure to alpha,beta-methylene ATP 1 microM to desensitize P2x-purinoceptors reduced the response to ATP 1 mM by 91% in otherwise untreated tissues, but did not reduce the response to ATP 1 mM in tissues exposed throughout to iso-PPADS 320 microM, suramin 320 microM or reactive blue 2 100 microM.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH Terms
Adenosine Triphosphate/analogs & derivatives,pharmacology,physiology Animals In Vitro Techniques Kinetics Male Muscle Contraction/drug effects,physiology Muscle, Smooth/drug effects,physiology,ultrastructure Purinergic P2 Receptor Antagonists Rats Rats, Wistar Receptors, Purinergic P2/physiology Vas Deferens/drug effects,physiology,ultrastructure
Chemicals
Purinergic P2 Receptor Antagonists Receptors, Purinergic P2 Adenosine Triphosphate alpha,beta-methyleneadenosine 5'-triphosphate
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bültmann R
Pharmakologisches Institut, Freiburg, Germany.
Starke K
References (24)
24 references, click to expand
  1. An assessment of the antagonistic activity of reactive blue 2 at P1- and P2-purinoceptors: supporting evidence for purinergic innervation of the rabbit portal vein.
    Eur J Pharmacol. 1987 Aug 4;140(1):47-53 PMID: 3622623
  2. Discrimination between two types of P2 purinoceptors by suramin in rat hepatocytes.
    Eur J Pharmacol. 1992 Aug 3;226(4):363-5 PMID: 1397062
  3. P2-purinoceptor antagonists.
    Ann N Y Acad Sci. 1990;603:182-96; discussion 196-7 PMID: 2291520
  4. P2 purinoceptor-mediated cyclic AMP accumulation in bovine vascular smooth muscle cells.
    Eur J Pharmacol. 1992 Sep 1;227(1):25-31 PMID: 1330637
  5. An ATP-sensitive conductance in single smooth muscle cells from the rat vas deferens.
    J Physiol. 1988 Jul;401:361-80 PMID: 2459375
  6. Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli.
    Br J Pharmacol. 1990 Mar;99(3):617-21 PMID: 2331585
  7. Pharmacological characterization of purinergic receptors in the rat vas deferens.
    J Pharmacol Exp Ther. 1983 Jan;224(1):40-5 PMID: 6294281
  8. Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery.
    Br J Pharmacol. 1990 Nov;101(3):645-9 PMID: 2076483
  9. Comparison of the effects of arylazido aminopropionyl ATP (ANAPP3), an ATP antagonist, on responses of the smooth muscle of the guinea-pig vas deferens to ATP and related nucleotides.
    Eur J Pharmacol. 1982 Dec 3;85(3-4):277-90 PMID: 6295784
  10. Comparison of contractions of the smooth muscle of the guinea-pig vas deferens induced by ATP and related nucleotides.
    Eur J Pharmacol. 1982 Jul 9;81(2):193-204 PMID: 7117373
  11. P2-purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2y-but not the P2x-purinoceptor.
    Br J Pharmacol. 1987 Feb;90(2):383-91 PMID: 3828656
  12. The ontogeny of purinoceptors in rat urinary bladder and duodenum.
    Br J Pharmacol. 1990 Aug;100(4):874-8 PMID: 2207506
  13. Two dissociable phases in the contractile response of the guinea pig isolated vas deferens to adenosine triphosphate.
    J Pharmacol Exp Ther. 1990 Jun;253(3):993-1001 PMID: 2359034
  14. Interaction of adenine nucleotides, UTP and suramin in mouse vas deferens: suramin-sensitive and suramin-insensitive components in the contractile effect of ATP.
    Naunyn Schmiedebergs Arch Pharmacol. 1990 Aug;342(2):198-205 PMID: 2234104
  15. Solubilization and molecular size determination of the P2x purinoceptor from rat vas deferens.
    J Biol Chem. 1992 Sep 5;267(25):17581-7 PMID: 1387637
  16. Adrenergic and purinergic cotransmission in nicotine-evoked vasoconstriction in rabbit ileocolic arteries.
    Naunyn Schmiedebergs Arch Pharmacol. 1991 Aug;344(2):174-82 PMID: 1944611
  17. Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens.
    Eur J Pharmacol. 1992 Sep 10;220(1):1-10 PMID: 1330614
  18. Possible subtypes of ATP receptor producing contraction of rat vas deferens, revealed by cross-desensitisation.
    Gen Pharmacol. 1989;20(1):61-4 PMID: 2707574
  19. A study of the purinoceptors mediating contraction in the rat colon.
    Br J Pharmacol. 1990 Aug;100(4):753-6 PMID: 1698498
  20. PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.
    Eur J Pharmacol. 1992 Jul 7;217(2-3):217-9 PMID: 1330591
  21. Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens.
    Br J Pharmacol. 1988 Feb;93(2):243-5 PMID: 3359103
  22. Is there a basis for distinguishing two types of P2-purinoceptor?
    Gen Pharmacol. 1985;16(5):433-40 PMID: 2996968
  23. P1- and P2-purinoceptor subtypes--an update.
    Arch Int Pharmacodyn Ther. 1990 Jan-Feb;303:30-50 PMID: 2196860
  24. Characterization of prejunctional purinoceptors on adrenergic nerves of the rat caudal artery.
    Naunyn Schmiedebergs Arch Pharmacol. 1988 Sep;338(3):221-7 PMID: 3194034
Article Info
Journal
Naunyn-Schmiedeberg's archives of pharmacology
Abbr.
Naunyn Schmiedebergs Arch Pharmacol
ISSN
0028-1298
Published
1994-01-00
Pages
74-80
Language
English
Region
Germany
NLM ID
0326264
Subset
IM
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com